Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
US Department of Justice
Baxter
Medtronic
Covington
Chinese Patent Office
Queensland Health
Express Scripts

Generated: July 17, 2018

DrugPatentWatch Database Preview

Dextrothyroxine sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for dextrothyroxine sodium and what is the scope of dextrothyroxine sodium patent protection?

Dextrothyroxine sodium
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for dextrothyroxine sodium
Synonyms for dextrothyroxine sodium
(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid
(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d
(2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
(R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid
(R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoicacid
051T490
0H00N2AHSP
137-53-1
3,3',5,5'-Tetraiodo-d-thyronine, sodium salt
3:5:3':5'-Tetraiodo-D-thyronine sodium
4W9K63FION
51-49-0
7054-08-2
7548-09-6
AC1L1RL4
AC1Q1V3J
AC1Q5R0S
ACT03142
AK-89309
AK310856
AKOS007930308
AKOS027321192
AM003578
AM015372
AN-41606
ANW-63155
API0002505
AX8033885
BCBcMAP01_000232
BDBM50225220
Biotirmone
C-47152
C15H10I4NO4.H2O.Na
C15H11I4NO4
CAS-51-48-9
CHEBI:30659
CHEMBL3545058
CHEMBL559
Choloxin
Choloxin (TN)
CTK8B9805
D-4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzylalanine
D-T4
D-T4 sodium
D-T4 Thyroid Hormone
D-Thyroxine
D-Thyroxine sodium salt
D-Thyroxine, 99%
D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt
D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt (9CI)
D-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt hydrate
D03750
D03TPR
DB00509
Debetrol
Destrotirossina sodica
Destrotirossina sodica [DCIT]
Dethyrona
Detyroxin
Dextroid
Dextrothyroxine
Dextrothyroxine sodique
Dextrothyroxine sodique [INN-French]
Dextrothyroxine Sodium (anhydrous)
Dextrothyroxine sodium (USAN)
Dextrothyroxine sodium [INN]
Dextrothyroxine sodium [USAN:INN]
Dextrothyroxine sodium [USAN:USP:INN]
Dextrothyroxine sodium anhydrous
Dextrothyroxinum
Dextrothyroxinum natricum
Dextrothyroxinum natricum [INN-Latin]
Dextrotiroxina sodica
Dextrotiroxina sodica [INN-Spanish]
Dextroxin
DTXSID60199000
DTXSID60220803
dynothel
EINECS 200-102-7
EINECS 205-301-2
FT-0675208
GTPL6951
I14-54064
J60FX7V025
KB-209823
KB-50481
KS-00000KLZ
Lisolipin
LS-153821
LS-175203
LS-176820
MFCD00063056
MolPort-003-901-019
monosodium d-thyroxine
Monosodium D-thyroxine hydrate
Nadrothyron D
NCGC00016228-01
O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine
Q-201830
SCHEMBL582058
SCHEMBL61194
SCHEMBL7112166
SMP1_000296
SODIUM (2R)-2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]PROPANOATE
Sodium (R)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate
Sodium d-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine
Sodium D-3,3',5,5'-tetraiodothyronine
Sodium D-T4
Sodium D-thyroxine
Sodium dextrothyroxine
Sodium-D-thyroxine
ST075205
ST24035310
T4 (LIOTRIX)
Thyroxine monosodium salt, D-
Thyroxine, monosodium salt, d-
TR-018335
Travenon
UNII-0H00N2AHSP
UNII-4W9K63FION
UNII-J60FX7V025
UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-GFCCVEGCSA-N
XUIIKFGFIJCVMT-GFCCVEGCSA-N
YDTFRJLNMPSCFM-UTONKHPSSA-M
ZINC3830994

US Patents and Regulatory Information for dextrothyroxine sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
AstraZeneca
Covington
QuintilesIMS
Moodys
Merck
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.